Sierra Oncology

• NCT02797977

  Phase 1/2, Completed, 153 people, 14 Jun 2016

• NCT02258607

  Phase 1, Terminated, 21 people, 7 Oct 2014

• NCT02244489

  Phase 1, Terminated, 16 people, 19 Sept 2014

• NCT01969838

  Phase 3, Completed, 432 people, 25 Oct 2013

• Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat

  Consulting or advice, Fees or honoraria, Board or leadership role, 12 Jan 2026

Sources: pubmed.ncbi.nlm.nih.gov